These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38520219)

  • 1. Comprehensive evaluation of cytomorphologic, histologic, and molecular features of DICER1-altered thyroid lesions on FNA: A multipractice experience.
    Lengyel K; Lubin DJ; Hsiao WY; Sirotnikov S; Luo G; Roberts JW; Shi Q; Magliocca K; Lewis MM; Sears DL; Ilyas G; Rogers BB; Viswanathan K
    Cancer Cytopathol; 2024 Jun; 132(6):359-369. PubMed ID: 38520219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomorphologic features of thyroid disease in patients with DICER1 mutations: A report of cytology-histopathology correlation in 7 patients.
    Darbinyan A; Morotti R; Cai G; Prasad ML; Christison-Lagay E; Dinauer C; Adeniran AJ
    Cancer Cytopathol; 2020 Oct; 128(10):746-756. PubMed ID: 32897650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid nodules with DICER1 mutation or PTEN alteration: A comparative cytologic, clinical, and molecular study of 117 FNA cases.
    Jitpasutham T; Andrianus S; Gubbiotti M; Nosé V; Baloch ZW; Madrigal E; Faquin WC
    Cancer Cytopathol; 2024 Jun; 132(6):370-385. PubMed ID: 38558329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomorphologic features of thyroid nodules harboring thyroid adenoma-associated fusion: A single institutional review of 11 cases.
    Roberts JW; Lubin DJ; Shi Q; Viswanathan K
    Diagn Cytopathol; 2022 Jul; 50(7):327-334. PubMed ID: 35347884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An institutional experience with DICER1 mutated thyroid nodules-evaluating the cytomorphology and molecular phenotype.
    Lee SH; Vadlamudi C; Zhao Q; Yilmaz O; Cerda S
    J Am Soc Cytopathol; 2022; 11(6):335-344. PubMed ID: 35934646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant teratomas of the thyroid gland: clinico-radiologic and cytomorphologic features of a rare entity.
    Miller DL; Thompson LDR; Bishop JA; Rooper LM; Ali SZ
    J Am Soc Cytopathol; 2020; 9(4):221-231. PubMed ID: 32448730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany.
    Eszlinger M; Böhme K; Ullmann M; Görke F; Siebolts U; Neumann A; Franzius C; Adam S; Molwitz T; Landvogt C; Amro B; Hach A; Feldmann B; Graf D; Wefer A; Niemann R; Bullmann C; Klaushenke G; Santen R; Tönshoff G; Ivancevic V; Kögler A; Bell E; Lorenz B; Kluge G; Hartenstein C; Ruschenburg I; Paschke R
    Thyroid; 2017 Mar; 27(3):402-411. PubMed ID: 28071986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
    Paulson VA; Shivdasani P; Angell TE; Cibas ES; Krane JF; Lindeman NI; Alexander EK; Barletta JA
    Thyroid; 2017 Apr; 27(4):506-511. PubMed ID: 28114855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytological features and nuclear scores: Diagnostic tools in preoperative fine needle aspiration of indeterminate thyroid nodules with RAS or BRAF K601E mutations?
    Ravella L; Lopez J; Descotes F; Giai J; Lapras V; Denier ML; Borson-Chazot F; Lifante JC; Decaussin-Petrucci M
    Cytopathology; 2021 Jan; 32(1):37-44. PubMed ID: 32803788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive Follicular Variant of Papillary Thyroid Carcinoma and the Afirma Gene-Expression Classifier.
    Wong KS; Angell TE; Strickland KC; Alexander EK; Cibas ES; Krane JF; Barletta JA
    Thyroid; 2016 Jul; 26(7):911-5. PubMed ID: 27219469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
    Hyeon J; Ahn S; Shin JH; Oh YL
    Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroblastoma: A DICER1-associated embryonal neoplasm and fine needle aspiration diagnostic criteria.
    Jitpasutham T; Faquin WC; Torous VF; Nosé V
    Diagn Cytopathol; 2023 May; 51(5):E142-E148. PubMed ID: 36688366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.
    Bellevicine C; Sgariglia R; Migliatico I; Vigliar E; D'Anna M; Nacchio MA; Serra N; Malapelle U; Bongiovanni M; Troncone G
    Cancer Cytopathol; 2018 May; 126(5):317-325. PubMed ID: 29469940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Prospective Analysis.
    Strickland KC; Vivero M; Jo VY; Lowe AC; Hollowell M; Qian X; Wieczorek TJ; French CA; Teot LA; Sadow PM; Alexander EK; Cibas ES; Barletta JA; Krane JF
    Thyroid; 2016 Oct; 26(10):1466-1471. PubMed ID: 27457786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining thyroid spherules: A benign cytomorphologic feature that mimics microfollicles.
    Costigan DC; Shaar M; Frates MC; Alexander EK; Barletta JA; Cibas ES
    Cancer Cytopathol; 2020 Mar; 128(3):171-176. PubMed ID: 31856389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DICER1 Mutations Do Not Always Indicate Dismal Prognosis in Pediatric Poorly Differentiated Thyroid Carcinomas.
    Yegen G; Altay AY; Yılmaz İ; İşcan Y; Sormaz İC; Aksakal N; Önder S; Mete Ö
    Endocr Pathol; 2023 Sep; 34(3):279-286. PubMed ID: 37574466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semiquantitative assessment of cytomorphologic features can predict mutation status of thyroid nodules with indeterminate cytologic diagnosis.
    Shahi M; Bloechl SJ; Vogel RI; Shrestha R; Krigman HR; Evasovich M; Burmeister LA; Amin K
    Hum Pathol; 2019 Nov; 93():81-89. PubMed ID: 31437520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.
    Adeniran AJ; Hui P; Chhieng DC; Prasad ML; Schofield K; Theoharis C
    Acta Cytol; 2011; 55(6):570-5. PubMed ID: 22156468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of distinct cytomorphologic features in the diagnosis of NIFTP at the time of preoperative FNA: Implications for patient management.
    Chandler JB; Colunga M; Prasad ML; Callender GG; Quinn C; Chhieng D; Adeniran AJ
    Cancer Cytopathol; 2017 Nov; 125(11):865-875. PubMed ID: 28834409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
    Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
    Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.